"Targeting Launch in the Fourth Quarter"

Medytox announced on September 28 that it has received product approval for its hyaluronic acid filler, 'Newramis Volume Lidocaine', from the National Medical Products Administration (NMPA) of China.


Medytox Newramis Volume Lidocaine. Medytox

Medytox Newramis Volume Lidocaine. Medytox

View original image

In addition to 'Newramis Deep Lidocaine', which has already been approved in China, Medytox has now added 'Newramis Volume Lidocaine', expanding its product lineup to a total of two hyaluronic acid fillers. 'Newramis' will be sold in China under the brand name 'Fillux'.



A Medytox representative stated, "We plan to expand our local, customized product portfolio, proceed with follow-up procedures through close cooperation with our partner company, and continue our global growth momentum with the goal of launching in the fourth quarter."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing